BRIEF-Neon Therapeutics To Collaborate with Merk on Clinical Trial (MRK)

Dec 7 (Reuters) - Merck & Co Inc:

* NEON THERAPEUTICS ANNOUNCES CLINICAL TRIAL COLLABORATION WITH MERCK

* NEON THERAPEUTICS - ENTERED CLINICAL TRIAL COLLABORATION WITH MERCK TO EVALUATE CO'S NEOANTIGEN VACCINE, NEO-PV-01, IN COMBINATION WITH MERCK'S KEYTRUDA

* NEON THERAPEUTICS SAYS COLLABORATION AGREEMENT IS BETWEEN CO AND MERCK, THROUGH A SUBSIDIARY; ADDITIONAL DETAILS WERE NOT DISCLOSED.

* NEON THERAPEUTICS - CO, MERCK TO WORK ON PHASE 1B TRIAL EXAMINING SAFETY, PRELIMINARY EFFICACY OF NEO-PV-01 COMBINED WITH KEYTRUDA, AMONG OTHERS Source text for Eikon: Further company coverage:

See Also:

• BRIEF-Advanced Accelerator Applications Announces Commencement Of Novartis Tender Offer

• BRIEF-Ciena Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.46

• BRIEF-GE Power's Planned 12,000 Headcount Reduction To Affect Employees Primarily Outside The U.S.